Latest filings (excl ownership)
CT ORDER
Confidential treatment order
8 Nov 10
15-12B
Securities registration termination
3 May 10
CT ORDER
Confidential treatment order
28 Apr 10
8-K
Completion of Acquisition or Disposition of Assets
23 Apr 10
25-NSE
Exchange delisting
22 Apr 10
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Apr 10
SC TO-T/A
Third party tender offer statement (amended)
20 Apr 10
10-K/A
2009 FY
Annual report (amended)
19 Apr 10
SC TO-T/A
Third party tender offer statement (amended)
14 Apr 10
SC 14D9
Tender offer solicitation
13 Apr 10
SC 14D9/A
Tender offer solicitation (amended)
8 Apr 10
SC TO-T/A
Third party tender offer statement (amended)
8 Apr 10
8-K
Facet Biotech Announces Two Presentations at American Academy of Neurology Annual Meeting
5 Apr 10
SC 14D9/A
Tender offer solicitation (amended)
5 Apr 10
SC 14D9/A
Tender offer solicitation (amended)
30 Mar 10
SC 14D9
Tender offer solicitation
23 Mar 10
SC TO-T
Third party tender offer statement
23 Mar 10
SC TO-C
Information about tender offer
15 Mar 10
8-A12B/A
Registration of securities on exchange (amended)
11 Mar 10
8-K
Entry into a Material Definitive Agreement
10 Mar 10
SC TO-C
Information about tender offer
10 Mar 10
SC TO-C
Information about tender offer
10 Mar 10
8-K
Results of Operations and Financial Condition
26 Feb 10
10-K
2009 FY
Annual report
24 Feb 10
8-K
Regulation FD Disclosure
9 Feb 10
8-K
Termination of a Material Definitive Agreement
3 Feb 10
8-K
Entry into a Material Definitive Agreement
26 Jan 10
8-K
Facet Biotech Announces Enrollment of First Patient In Phase 2 Study of Elotuzumab In Patients with Relapsed Multiple Myeloma
11 Jan 10
SC 14D9/A
Tender offer solicitation (amended)
17 Dec 09
SC TO-T/A
Third party tender offer statement (amended)
17 Dec 09
8-A12B/A
Registration of securities on exchange (amended)
16 Dec 09
8-K
Entry into a Material Definitive Agreement
16 Dec 09
SC 14D9/A
Tender offer solicitation (amended)
16 Dec 09
8-K
Entry into a Material Definitive Agreement
15 Dec 09
SC 14D9/A
Tender offer solicitation (amended)
15 Dec 09
SC TO-T/A
Third party tender offer statement (amended)
15 Dec 09
SC TO-T/A
Third party tender offer statement (amended)
11 Dec 09
SC 14D9/A
Tender offer solicitation (amended)
10 Dec 09
8-K
Facet Biotech Presents Scientific Data Regarding Next-generation
8 Dec 09
Latest ownership filings
SC 13D
ABBOTT LABORATORIES
21 Apr 10
SC 13D/A
GAMCO INVESTORS, INC. ET AL
21 Apr 10
SC 13D
GAMCO INVESTORS, INC. ET AL
16 Apr 10
SC 13D/A
BAUPOST GROUP LLC/MA
12 Apr 10
SC 13D
PERRY CORP
19 Mar 10
SC 13D/A
BAUPOST GROUP LLC/MA
17 Mar 10
SC 13D/A
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD
10 Mar 10
SC 13D/A
BIOTECHNOLOGY VALUE FUND L P
2 Feb 10